Inbio Ventures
About
Inbio Ventures is a venture capital firm that seeks to invest early stage and startups
- Moscow,Moscow City,Russian Federation
- http://www.inbio-ventures.com
Details
- Founded date
- Jan 1, 2013
- Operating Status
- Active
- Investor Type
- Venture Capital
We are the ambitious team of professionals with comprehensive experience in academic and biopharmaceutical industry, drug discovery and development, venture investments. We are supported by the Advisory Board of internationally recognized KOLs in various therapeutic areas. We are dedicated to investing in breakthrough drug development projects worldwide.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 5, 2017
Neon Therapeutics
|
Series B | $36M | Bioinformatics | — |
|
Jan 5, 2017
Neon Therapeutics
|
Series B | $70M | Bioinformatics | — |
|
Aug 18, 2016
Avelas Biosciences
|
Series C | $20M | Biotechnology | — |
|
Jul 12, 2016
TransMedics
|
Private Equity（PE） | $12.50M | Health Care | — |
|
May 26, 2016
TransMedics
|
Series F | $51.20M | Health Care | Yes |
Employee Profiles
Exits
Inbio Ventures has had 8 exits. Inbio Ventures most notable exits include TransMedics , Neon Therapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| May 1, 2019 | TransMedics | IPO | Health Care | Detail |
| Jun 26, 2018 | Neon Therapeutics | M&A | Bioinformatics | Detail |
| Apr 23, 2018 | Argos Therapeutics | M&A | Biotechnology | Detail |
| Nov 2, 2017 | Allena Pharmaceuticals | IPO | Biotechnology | Detail |
| Jan 27, 2017 | Jounce Therapeutics | M&A | Biotechnology | Detail |
